s6y

3 Processa Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001567619-22-014304

Documents

  1. FORM 3 3
  2. POWER OF ATTORNEY EX-24.1

On sec.gov